Home/Pipeline/DBI-EPIbreath®

DBI-EPIbreath®

Therapeutic Drug Monitoring

DevelopmentActive

Key Facts

Indication
Therapeutic Drug Monitoring
Phase
Development
Status
Active
Company

About Deep Breath Intelligence

Deep Breath Intelligence is a Zurich-based diagnostics company pioneering the field of breath metabolomics. Its core platform integrates proprietary breath collection hardware (BreathCollector, BreathInjector) with a sophisticated analytical backend using SESI-HRMS and AI/ML to identify disease biomarkers. The company operates a hybrid business model, selling research-use products and offering fee-for-service contract research, while developing its first software-as-a-medical-device, DBI-EPIbreath®, for therapeutic drug monitoring. Positioned at the intersection of non-invasive diagnostics and personalized medicine, DBI targets both the research market and future clinical applications.

View full company profile

Other Therapeutic Drug Monitoring Drugs